LDN and Auto-immune disease, HIV/Aids, Cancer and MS:

• LDN and HIV/AIDS
• Per Dr. Bihari, patients who took LDN had decreased deterioration of CD4+ cells.
• In Dr. Bihari’s practice, 350 AIDS patients were given LDN, along with standard AIDS therapies. Over 7 years, studies showed that about 85% of patients had no detectable levels of the virus, with no side effects and higher efficacy than most AIDS treatments.
 

• LDN and Cancer
• LDN has been shown to inhibit tumors in the laboratory setting (Mechanism: production of endorphins and enkephalins which work on tumors’ opioid receptors and cause cancer cell death), and may also increase natural killer cells.
• In Dr. Bihari’s practice, he reported having 300 patients who had failed standard cancer treatments. Of those, about half of them showed improved with LDN, after 4 to 6 months of initiating therapy, and greater than 33% showed tumor shrinkage.
 

• LDN and MS
• Low endorphin levels impair helper T cells which lead to myelin destruction. LDN restores endorphin levels.
• In Dr. Bihari’s practice, he had about 400 M.S. patients.
• After starting LDN, less than 1% of patients experienced a new M.S. attack.
 

• LDN and Auto-immune disease
• In treating other autoimmune diseases, all patients had a decrease in illness progression, but there were patients who experienced remission.